The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...

For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The the US Food and Drug Administration (FDA) has approved the first medication ... “Zepbound promotes weight loss and has been shown to reduce apnea events,” Troxel noted.

The FDA first approved Zepbound to treat obesity in November ... to treat Type 2 diabetes and became popular as an off-label weight-loss treatment. Tirzepatide works by stimulating two hormones ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

The FDA's approval is based on data from two trials ... and older and those with disabilities are barred from covering weight-loss treatments, though the Biden administration has proposed to ...